Literature DB >> 21511865

Evaluation of parenchymal neuro-behçet disease by using susceptibility-weighted imaging.

S Albayram1, S Saip, Z I Hasiloglu, M Teke, E Ceyhan, M Tutuncu, H Selcuk, A Kina, A Siva.   

Abstract

BACKGROUND AND
PURPOSE: Neurologic involvement in Behçet disease, also known as NBD, is one of the most devastating manifestations of the disease. The precise pathologic mechanism of parenchymal NBD lesions has not been established. We evaluated lesion characteristics and probable venous hemorrhage in parenchymal NBD by using SWI, and we compared the imaging results with conventional MR imaging sequences.
MATERIALS AND METHODS: We performed cranial MR imaging by using a 1.5T scanner in 23 patients with a definitive diagnosis of parenchymal NBD. We compared the proportion of lesion detection and the performance of hemorrhagic detection with the T2 FSE, T2*GE, and SWI magnitude, and SWI mIP by using the χ(2) test.
RESULTS: The proportion of lesion detection with both SWI magnitude and SWI MinMIP was significantly larger than that with T2*GE. The proportions of lesion detection among all other pairs of methods were not significantly different according to the corresponding P value (χ(2) = 17.4929, df = 3, P = .0006). Proportions of hypointense hemorrhagic lesions with T2 FSE and T2*GE were not significantly different, and likewise for the proportions of hypointense hemorrhagic lesions with SWI magnitude and SWI mIP. In contrast, the proportions of hypointense hemorrhagic lesions with SWI magnitude and SWI mIP were significantly larger than that with T2 FSE and T2*GE (χ(2) = 108.5396, df = 3, P < .0001).
CONCLUSIONS: Most of the lesions in parenchymal NBD were found to be hemorrhagic with SWI, supporting the proposed venous theory in pathology. In addition, compared with T2 FSE and T2*GE sequences, SWI was more successful in the determination of widespread involvement of the disease, particularly in nonchronic cases.

Entities:  

Mesh:

Year:  2011        PMID: 21511865      PMCID: PMC8013155          DOI: 10.3174/ajnr.A2477

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  40 in total

1.  Neurological complications in Behçet's syndrome.

Authors:  D Kidd; A Steuer; A M Denman; P Rudge
Journal:  Brain       Date:  1999-11       Impact factor: 13.501

2.  Evaluation of diagnostic ('classification') criteria in Behçet's disease--towards internationally agreed criteria. The International Study Group for Behçet's disease.

Authors: 
Journal:  Br J Rheumatol       Date:  1992-05

3.  Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group.

Authors:  G Akman-Demir; P Serdaroglu; B Tasçi
Journal:  Brain       Date:  1999-11       Impact factor: 13.501

Review 4.  Neuro-Behçet disease. A review.

Authors:  Afshin Borhani Haghighi; Rahman Pourmand; Ali-Reza Nikseresht
Journal:  Neurologist       Date:  2005-03       Impact factor: 1.398

5.  Hypertensive pontine microhemorrhage.

Authors:  Jee-Hyang Jeong; Soo Jin Yoon; Sue J Kang; Kyung Gyu Choi; Duk L Na
Journal:  Stroke       Date:  2002-04       Impact factor: 7.914

6.  Behçet's disease: diagnostic and prognostic aspects of neurological involvement.

Authors:  A Siva; O H Kantarci; S Saip; A Altintas; V Hamuryudan; C Islak; N Koçer; H Yazici
Journal:  J Neurol       Date:  2001-02       Impact factor: 4.849

7.  Pseudotumoral neuro-Behçet's disease.

Authors:  C Geny; P Cesaro; F Heran; J P Nguyen; J Poirier; J D Degos
Journal:  Surg Neurol       Date:  1993-05

8.  Hemorrhagic shearing lesions in children and adolescents with posttraumatic diffuse axonal injury: improved detection and initial results.

Authors:  Karen A Tong; Stephen Ashwal; Barbara A Holshouser; Lori A Shutter; Gwenael Herigault; E Mark Haacke; Daniel K Kido
Journal:  Radiology       Date:  2003-05       Impact factor: 11.105

9.  Histopathology of central nervous system lesions in Behçet's disease.

Authors:  Shunsei Hirohata
Journal:  J Neurol Sci       Date:  2007-10-31       Impact factor: 3.181

10.  Improved preoperative evaluation of cerebral cavernomas by high-field, high-resolution susceptibility-weighted magnetic resonance imaging at 3 Tesla: comparison with standard (1.5 T) magnetic resonance imaging and correlation with histopathological findings--preliminary results.

Authors:  Katja Pinker; Ioannis Stavrou; Pavol Szomolanyi; Romana Hoeftberger; Michael Weber; Andreas Stadlbauer; Iris M Noebauer-Huhmann; Engelbert Knosp; Siegfried Trattnig
Journal:  Invest Radiol       Date:  2007-06       Impact factor: 6.016

View more
  5 in total

Review 1.  Behçet's Syndrome and Nervous System Involvement.

Authors:  Uğur Uygunoğlu; Aksel Siva
Journal:  Curr Neurol Neurosci Rep       Date:  2018-05-23       Impact factor: 5.081

2.  Isolated superior striate vein thrombosis in adults.

Authors:  Bianca Mazini; Christophe Bonvin; Philippe Gailloud; Diego San Millán
Journal:  Interv Neuroradiol       Date:  2020-01-22       Impact factor: 1.610

3.  Increased T-bet/GATA-3 and ROR-γt /Foxp3 Ratios in Cerebrospinal Fluid as Potential Criteria for Definite Neuro-Behçet's Disease.

Authors:  Meriam Belghith; Olfa Maghrebi; Aroua Cherif; Khadija Bahrini; Zakaria Saied; Samir Belal; Samia Ben Sassi; Mohamed-Ridha Barbouche; Mariem Kchaou
Journal:  J Clin Med       Date:  2022-07-29       Impact factor: 4.964

Review 4.  Neuro-Behçet's disease in childhood: a focus on the neuro-ophthalmological features.

Authors:  Paolo Mora; Chiara Menozzi; Jelka G Orsoni; Pierangela Rubino; Livia Ruffini; Arturo Carta
Journal:  Orphanet J Rare Dis       Date:  2013-01-29       Impact factor: 4.123

Review 5.  Diagnosis and management of Neuro-Behçet's disease: international consensus recommendations.

Authors:  Seema Kalra; Alan Silman; Gulsen Akman-Demir; Saeed Bohlega; Afshin Borhani-Haghighi; Cris S Constantinescu; Habib Houman; Alfred Mahr; Carlos Salvarani; Petros P Sfikakis; Aksel Siva; Adnan Al-Araji
Journal:  J Neurol       Date:  2013-12-24       Impact factor: 4.849

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.